These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29298796)

  • 1. Development and Preclinical Validation of a Cysteine Knottin Peptide Targeting Integrin αvβ6 for Near-infrared Fluorescent-guided Surgery in Pancreatic Cancer.
    Tummers WS; Kimura RH; Abou-Elkacem L; Beinat C; Vahrmeijer AL; Swijnenburg RJ; Willmann JK; Gambhir SS
    Clin Cancer Res; 2018 Apr; 24(7):1667-1676. PubMed ID: 29298796
    [No Abstract]   [Full Text] [Related]  

  • 2. 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.
    Hackel BJ; Kimura RH; Miao Z; Liu H; Sathirachinda A; Cheng Z; Chin FT; Gambhir SS
    J Nucl Med; 2013 Jul; 54(7):1101-5. PubMed ID: 23670900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cystine Knot Peptide Targeting Integrin αvβ6 for Photoacoustic and Fluorescence Imaging of Tumors in Living Subjects.
    Zhang C; Kimura R; Abou-Elkacem L; Levi J; Xu L; Gambhir SS
    J Nucl Med; 2016 Oct; 57(10):1629-1634. PubMed ID: 27230926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Two Optical Probes for Imaging the Integrin α
    Ganguly T; Tang SY; Bauer N; Sutcliffe JL
    Mol Imaging Biol; 2020 Oct; 22(5):1170-1181. PubMed ID: 32002763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy.
    Reader CS; Vallath S; Steele CW; Haider S; Brentnall A; Desai A; Moore KM; Jamieson NB; Chang D; Bailey P; Scarpa A; Lawlor R; Chelala C; Keyse SM; Biankin A; Morton JP; Evans TJ; Barry ST; Sansom OJ; Kocher HM; Marshall JF
    J Pathol; 2019 Nov; 249(3):332-342. PubMed ID: 31259422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot-phase PET/CT study targeting integrin α
    Nakamoto R; Ferri V; Duan H; Hatami N; Goel M; Rosenberg J; Kimura R; Wardak M; Haywood T; Kellow R; Shen B; Park W; Iagaru A; Gambhir SS
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):184-193. PubMed ID: 34729628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A near-infrared phthalocyanine dye-labeled agent for integrin αvβ6-targeted theranostics of pancreatic cancer.
    Gao D; Gao L; Zhang C; Liu H; Jia B; Zhu Z; Wang F; Liu Z
    Biomaterials; 2015 Jun; 53():229-38. PubMed ID: 25890722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
    Boonstra MC; Tolner B; Schaafsma BE; Boogerd LS; Prevoo HA; Bhavsar G; Kuppen PJ; Sier CF; Bonsing BA; Frangioni JV; van de Velde CJ; Chester KA; Vahrmeijer AL
    Int J Cancer; 2015 Oct; 137(8):1910-20. PubMed ID: 25895046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus.
    Moore KM; Desai A; Delgado BL; Trabulo SMD; Reader C; Brown NF; Murray ER; Brentnall A; Howard P; Masterson L; Zammarchi F; Hartley JA; van Berkel PH; Marshall JF
    Theranostics; 2020; 10(7):2930-2942. PubMed ID: 32194845
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Ren J; Zhu S; Zhang G; Tan X; Qiu L; Lin J; Jiang L
    Mol Pharm; 2022 Jul; 19(7):2620-2628. PubMed ID: 35674464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of a radioiodinated peptide probe targeting αvβ6 integrin for the detection of pancreatic ductal adenocarcinoma.
    Ueda M; Fukushima T; Ogawa K; Kimura H; Ono M; Yamaguchi T; Ikehara Y; Saji H
    Biochem Biophys Res Commun; 2014 Mar; 445(3):661-6. PubMed ID: 24583127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells.
    Man YKS; Davies JA; Coughlan L; Pantelidou C; Blázquez-Moreno A; Marshall JF; Parker AL; Halldén G
    Mol Cancer Ther; 2018 Feb; 17(2):575-587. PubMed ID: 29367266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a
    Ui T; Ueda M; Higaki Y; Kamino S; Sano K; Kimura H; Saji H; Enomoto S
    Bioorg Med Chem; 2020 Jan; 28(1):115189. PubMed ID: 31740201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECT/CT Imaging, Biodistribution and Radiation Dosimetry of a
    Sachindra S; Hellberg T; Exner S; Prasad S; Beindorff N; Rogalla S; Kimura R; Gambhir SS; Wiedenmann B; Grötzinger C
    Front Oncol; 2021; 11():684713. PubMed ID: 34136410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Translation of a
    Feng X; Wang Y; Lu D; Xu X; Zhou X; Zhang H; Zhang T; Zhu H; Yang Z; Wang F; Li N; Liu Z
    J Nucl Med; 2020 Oct; 61(10):1461-1467. PubMed ID: 32086242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
    Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
    Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects.
    Kimura RH; Miao Z; Cheng Z; Gambhir SS; Cochran JR
    Bioconjug Chem; 2010 Mar; 21(3):436-44. PubMed ID: 20131753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer.
    Olson MT; Aguilar EN; Brooks CL; Isder CC; Muilenburg KM; Talmon GA; Ly QP; Carlson MA; Hollingsworth MA; Mohs AM
    Mol Pharm; 2022 Oct; 19(10):3586-3599. PubMed ID: 35640060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer.
    Brown NF; Murray ER; Cutmore LC; Howard P; Masterson L; Zammarchi F; Hartley JA; van Berkel PH; Marshall JF
    Pancreatology; 2024 May; 24(3):445-455. PubMed ID: 38519394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin αvβ₆-Targeted SPECT Imaging for Pancreatic Cancer Detection.
    Liu Z; Liu H; Ma T; Sun X; Shi J; Jia B; Sun Y; Zhan J; Zhang H; Zhu Z; Wang F
    J Nucl Med; 2014 Jun; 55(6):989-94. PubMed ID: 24711651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.